.jpg)
.png)
All
Read about some of the highlighted sessions and see images from day two of the 2018 Scientific Sessions. Share your thoughts on social media using the hashtag, #NLASessions.
Pledges to the Foundation of the National Lipid Association The Foundation of the National Lipid Association has joined #GivingTuesday, a global day of giving that harnesses the collective power of individuals, communities and organizations to encourage philanthropy and to... more
National Lipid Association Unveils New Mission to Advance Lipidology and Cardiometabolic Health JACKSONVILLE, Fla. – (May 31, 2024) - The National Lipid Association (NLA) is proud to announce its renewed mission: “To enhance the science and practice of lipidology and promote optimal... more
The NLA is excited to share that we will host our first-ever virtual Scientific Sessions! Due to current travel restrictions and gathering limitations in the city of Chicago, the NLA has made the difficult decision to rescope our 2020 Scientific Sessions into a fully virtual conference held live on... more
h3 a { color: #55191B !imortant; font-size: 15px; text-decoration: underline; } p a { color: #CC0033 !important; font-style: normal; font-weight: normal; font-size: 13px !important; text-decoration: none !important; } #border { border: 3px #... more
Merck (NYSE:MRK), known as MSD outside of the United States and Canada, announced that the REVEAL (Randomized EValuation of the Effects of Anacetrapib through Lipid modification) outcomes study of anacetrapib met its primary endpoint, significantly reducing major coronary events (defined as the... more
.field-type-fivestar { display: none; } .tab {margin-left: 100px; } .tabt {margin-left:300px; } The National Lipid Association Risk Assessment Tool is based on the NLA’s 2014 Publication: NLA Recommendations for the Patient-Centered Management of Dyslipidemia Part 1. The... more
The National Lipid Association recently convened an Expert Panel to draft a document that would serve as guidance to clinicians for treating patients with dyslipidemia. Our foremost goal was to harmonize guidelines among what has been presented in the past by the ATP panel, the American Heart... more
Have you recently authored a lipid-focused article in a journal or newsletter? If the content of the article was related to dyslipidemia or other lipid disorders and the audience for the journal or newsletter was healthcare professionals, provide the title of the article, name of the publication... more
Loretta is a 60-year-old white woman with a past medical history significant for hypercholesterolemia, mitral regurgitation, hypertension, pregnancy-induced hypertension (twice) and a family history of premature coronary heart disease (her father had myocardial infarction at age 53). Recent... more